WITHDRAWN: Metformin and 2-deoxy-D-glucose Synergistically Inhibit the Viability of Thyroid Papillary Carcinoma with BRAF Mutation by ROS-dependent PI3K/AKT Signaling Pathway

<p>Since the authors are not responding to the editor’s requests to fulfill the editorial requirement, therefore, the article hasbeen withdrawn from the website of the journal Anti-Cancer Agents in Medicinal Chemistry.</p><p>Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.</p><p>The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/pages/editorial-policies-main</p><p>BENTHAM SCIENCE DISCLAIMER:It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneouslysubmitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been publishedelsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden,and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriateaction against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authorsagree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.</p>